NVIC’s Online Vaccine Conference Rebroadcast This Weekend by Popular Demand
There was a young man walking down a deserted beach just before dawn. In the distance he saw a frail old man. As he approached the old man, he saw him picking up stranded starfish and throwing them, one by one, back into the sea. The young man gazed in wonder as the old man, […]
What Does Zinc Bring to the Table?
Story Highlights Zinc is a trace element necessary for human health and has many important benefits including anti-inflammatory properties and powerful immune system support. It has long been used to reduce the duration and severity of the common cold, which is generally caused by coronaviruses. Zinc is not made by or stored in the body […]
AAP Wants Children Enrolled in COVID-19 Vaccine Clinical Trials
The American Academy of Pediatrics (AAP) is asking federal officials to include children in COVID-19 vaccine trials.1 On September 29, 2020, Sara Goza, MD, president of the AAP, wrote a letter addressed to U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Food and Drug Administration (FDA) Commissioner Steven Hahn, MD stating, […]
Only Half of Americans Polled Say They Would Get COVID-19 Vaccine
In a poll conducted for CNN during Oct. 1-4, 2020, the Pennsylvania-based market research firm SSRS found that 51 percent of the 1,205 Americans surveyed said they would try to get a COVID-19 vaccine if it were widely available at a low cost, 45 percent said they would not and four percent had no opinion. Sixty […]
DES Tragedy Offers Cautionary Tale for COVID-19 Vaccine Mandates
The synthetic estrogen Diesthylstilbestrol (DES) was prescribed to pregnant women in the U.S. from 1938 to 1971 for the prevention of miscarriages and premature births. In 1953, published research showed that DES did not in fact prevent miscarriages or premature births. However, physicians continued to prescribe it until 1971, when the FDA warned that the […]
20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine
On Sept. 23, 2020, U.S. pharmaceutical and medical devices company Johnson & Johnson, Inc. announced the start of the Phase 3 human clinical trial for its experimental Ad26.COV2.S vaccine for COVID-19. The New Jersey-based company, which is partnering with its subsidiary Janssen Pharmaceutica NV of Belgium on development of the vaccine, is planning to enroll […]